Navigation Links
European Medicines Agency Grants Cell Therapeutics Orphan Drug Designation for Pixantrone in Diffuse Large B-Cell Lymphoma (DLBCL)
Date:12/21/2009

tone therapeutic for the treatment of lymphoma, leukemia, and breast cancer. Although they are sufficiently effective to be used as first-line (initial) treatment, they cause cumulative heart damage that may result in congestive heart failure many years later. As a result, there is a lifetime limit of anthracycline doses and most patients who previously have been treated with an anthracycline are not able to receive further anthracycline treatment if their disease returns.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.

Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_news.htm

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading price of the securities of CTI. Specifically, the risks and uncertainties that could affect the development of pixantrone include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general, and with pixantrone in particular, including, without limitation, the potential failure of pixantrone to prove safe and effective for the treatment of relapsed or refractory aggressive NHL as determined by the FDA or EMEA, and the possibility that the orphan drug designation, if grant
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer
2. European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient
3. A Drugs Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections
4. Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8
5. Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)
6. Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis
7. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
8. European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis
9. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
10. BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries
11. Solta Medical Announces New Fraxel re:store(R) Dual Laser System, Receives CE Mark for European Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 28, 2015 On the afternoon of August ... of CPI International, Inc. (CPI), plans to file its ... 2015 with the Securities and Exchange Commission and to ... quarter.  At 11 a.m. (EDT) on Wednesday, August 12, ... conjunction with this release that will be Web cast ...
(Date:7/28/2015)... 2015 A German Diabetes Center clinical study ... probiotic enriches human gut microbiota and modifies gut ... study involved daily administration of Nutraceutix,s L. reuteri ... patented BIO- tract ® delivery technology that ... their way to the intestinal tract. The ...
(Date:7/28/2015)... July 28, 2015 The Physician-Patient Alliance for ... fundraising campaign, " Surviving Your Hospital Stay ." ... they deserve! None of these patients went home from ... Executive Director, PPAHS) referring to the patient stories ... National Coalition to Promote Continuous Monitoring of Patients on ...
Breaking Medicine Technology:CPI International To Announce Third Quarter 2015 Financial Results 2Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2
... , ... (OTC Bulletin Board: HFGB), a leading developer and producer,of plant ... food production in Xi,an, China, today reported that in its,third ... Revenues for the quarter ended Sept. ...
... , NORTH HOLLYWOOD, Calif., Nov. ... a leading national hospitalist physician group practice company, announced today that ... ACP Hospitalist as one of the 2009 Top Ten Hospitalists ... of the magazine. , Dr. Vaidyan has been a practicing physician ...
Cached Medicine Technology:Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 2Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 3Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 4IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 3
(Date:7/28/2015)... , ... July 28, 2015 , ... ... products, announces Shelled Out, a new household invention that makes shelling eggs an ... billion by 2020,” says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:7/28/2015)... ... ... By 2016, the number of smartphones worldwide will surpass 2 billion. This means that ... increasing customer loyalty. However, capitalizing on this is not always obvious. Companies that do ... competitors. , The Open Mobile Summit 2015 is an influential gathering of mobile visionaries ...
(Date:7/28/2015)... ... July 28, 2015 , ... DuPont leaders today joined public ... learn more about the impact of U.S. collaborations with local partners under the ... agricultural development as an engine of broad-based economic growth in the region. ...
(Date:7/28/2015)... ... 2015 , ... opaJUMP! and O-PA! Performance Academy in ... associated with its training methods. This company is also the first to promise ... in early 2015, training yielded an average 80% improvement in functional health status ...
(Date:7/28/2015)... ... July 28, 2015 , ... Healthpointe ’s Cosmetic Laser ... skin to a smooth state, and reduces the appearance of fine lines and wrinkles. ... FDA-approved injectable gel to instantly add volume to your cheek area to correct age-related ...
Breaking Medicine News(10 mins):Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 2Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 2Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 3Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 4Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 5Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 6Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 7Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3
... Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, ... Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), has extended ... purchase of all outstanding Ordinary Shares of Taro Pharmaceutical ... at 5:00 p.m., New York City time, on Friday, ...
... finds that for some groups, survival odds after angioplasty ... News) -- A major international study pinpoints which people ... having bypass surgery than artery-opening angioplasty. , "Bypass surgery ... said Dr. Mark Hlatky, professor of health research and ...
... New Definition of ,Bedside Manner,WASHINGTON and RED BANK, N.J., ... (NWHRC) just released the latest issue of its ... Care Reform." The report coincides with the start ... support and awareness of the need for comprehensive health ...
... 20 -- Today, the Migraine Research Foundation (MRF) announced ... pediatric and adolescent migraine called FOR OUR CHILDREN. ... to further the understanding of migraine and its causes ... and adolescents. , Migraine is very common ...
... Message That Pulmonary Fibrosis Can Strike Anyone, Anywhere; Urges Americans ... March 20 Pulmonary Fibrosis (PF) claims a life every ... each year as to breast cancer; yet most Americans have ... someone they love. The Coalition for Pulmonary Fibrosis (CPF) ...
... is that hepatocyte necrosis is the main feature of ... role for hepatocyte apoptosis in this pathogenesis. It is ... in the pathogenesis of fulminant hepatic failure. To ascertain ... the protective effect of a cathepsin B inhibitor (CA-074Me) ...
Cached Medicine News:Health News:Sun Pharmaceutical Extends Tender Offer for Taro 2Health News:Sun Pharmaceutical Extends Tender Offer for Taro 3Health News:Diabetics and Elderly May Fare Better With Bypass 2Health News:Diabetics and Elderly May Fare Better With Bypass 3Health News:National Women's Health Report Addresses Issues of Uninsured Plus New Paradigms of Care 2Health News:New initiative to support pediatric migraine research is announced 2Health News:CPF Launches National PSA to Educate Public on Pulmonary Fibrosis 2Health News:CPF Launches National PSA to Educate Public on Pulmonary Fibrosis 3
Focus Toric Monthly lenses. All the advantages of Focus Monthly lenses, now available for patients with astigmatism. Recommended for daily wear. Also approved for extended wear (1-7 days)....
... Made Toric soft contact lenses let you enjoy ... soft toric lens in a lens custom made ... comfort is made possible by PC Technology™, which ... (PC), a substance found naturally in human cell ...
Soft contacts for even the most challenging astigmatic prescriptions. Custom-manufactured according to patient specific prescription, gives the most precise fit possible....
... Great vision and disposable lens convenience ... have astigmatism and want crisp, clear vision ... consider Vertex Toric. Vertex Toric lenses are ... process that produces a perfect edge on ...
Medicine Products: